Bone Morphogenetic Protein Signaling in Vascular Disease

Abstract excerpt

Pulmonary artery hypertension (PAH) patients exhibit elevated levels of inflammatory cytokines and infiltration of inflammatory cells in the lung. Concurrently, mutations of bmpr2, the gene encoding the type II receptor of bone morphogenetic proteins (BMP), are found in ∼75% of patients with familial PAH, but a possible nexus between increased inflammation and diminished BMP signaling has hitherto remained...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiac Fibrosis and Remodeling
• Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
• Share to Pulmonary Hypertension Research and Treatments